CHARLOTTE, N.C., March 27, 2025 /PRNewswire/ -- Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and ...

Vasorum USA, Inc, a privately held, commercial-stage medical device company dedicated to redefining vascular closure, today announced U.S. Food and Drug Administration (FDA) approval of the Celt ACD® ...

The U.S. small bore arterial vascular closure device market, valued at $600 million in 2023, is projected to reach $1 billion by 2032. This growth is driven by the increasing prevalence of ...

Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced ...

and Efficacy of a Novel External Compression Vascular Closure Device: The LockeT Study (interim study data) Abstract at the American College of Cardiology meeting titled Feasibility, Safety ...

Med Tech & Diagnostics Analysts, along with Dr. Rahul Doshi, an electrophysiology expert, discuss ablation, left atrial appendage closure, ...

Vasorum USA, Inc. announced FDA approval of the Celt ACD Plus system, which is designed for rapid arterial puncture closure ...

There are worries about delayed complications, but many places won’t get paid if AF patients don’t spend the night in ...

Disappointment over a cardiology board, an FDA approval, meeting news, and advice for practice—it’s all here this month.

LifeTech Scientific Corporation (the 'Company' or 'LifeTech', Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and ...